Analysis published 08 Jun 2026

AI-generated · cited to primary sources · not investment advice

Quick Heal Tech (539678) Jan 2026 Filing Analysis

01 · Management Credibility

Does management do what it says?

In progressIndia Pricing and Global Pricing Arbitrage
60/100

Despite a structural decline in the global consumer antivirus market, management reports that Quick Heal is experiencing the lowest decline compared to competitors, effectively holding its market share. (1 in progress across 1 tracked commitment)

Strategic Expansion in select focused geographies

Quick Heal Tech · Investor PPT · Jan 2026 · p.11
AI Copilot Integration Premium

Focus on maintaining market share in the Antivirus (AV) segment while positioning AntiFraud.AI to tackle financial frauds.

Positioning AntiFraud.AI to tackle the financial frauds Focus towards maintaining our market share in AV segment

Quick Heal Tech · Investor PPT · Jan 2026 · p.24

See the full cited Management analysis of Quick Heal Tech

Create free account →
04 · Risk

What could break the thesis?

Rule of 40 Benchmark

Profitability has significantly improved from the massive losses previously noted. PAT for Q3 FY26 is positive at ₹ 6.6 Cr, representing a massive 5909.1% YoY increase from a very low base. (1 easing)

Profit After Tax (PAT) 6.6 Cr... 5909.1% YoY

Quick Heal Tech · Investor PPT · Jan 2026 · p.28
India SaaS Market Approaching USD 100B by 2035

The company is successfully transitioning its enterprise mix. Cloud-based revenue now accounts for 35% of the enterprise business, up from 23% in FY 2024. (1 easing)

9M FY 2026 Cloud 35% On-Prem 65%

Quick Heal Tech · Investor PPT · Jan 2026 · p.21

See the full cited Risk analysis of Quick Heal Tech

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.